Subject of the day
ANIP
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $883.37M | +59.7% | |
| Operating income | $584.00K | -35.7% | |
| Net income | -$18.52M | +80.5% | |
| Cash from ops | $64.02M | +12.6% |
$74.77
▼ -0.35 (-0.5%)
| 52w hi | $98.81 |
|---|---|
| 52w lo | $70.49 |
| Vol | 321.02K |
| As of | Aug 13 |
Our score +0.07
| Short | -0.34 |
|---|---|
| Medium | +0.18 |
| Long | +0.68 |
computed 2026-08-13
ANI Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
| Market cap | $1.72B |
|---|---|
| Enterprise value | $1.86B |
| Trailing P/E | 16.29x |
| Forward P/E | 7.10x |
| EV / EBITDA | 8.88x |
| P / S (ttm) | 1.76x |
| Profit margin | 11.1% |
| Return on equity | 20.5% |
| Revenue growth | +25.9% |
| Earnings growth | +191.1% |
| Debt / equity | 104.83 |
| Beta vs SPX | 0.54 |
|---|---|
| Corr SPX | 0.24 |
| Annual vol | 36.1% |
| Annual ret | +20.4% |
| Sharpe | 0.57 |
| Max DD | -28.7% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.44 | |
| Sector | +0.12 | |
| Technical | -0.12 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $75.48 | $75.64 | $74.00 | $74.77 | 321.02K |
| Aug 12 | $73.72 | $75.35 | $73.27 | $75.12 | 466.50K |
| Aug 11 | $75.96 | $77.00 | $74.00 | $74.53 | 526.20K |
| Aug 10 | $77.02 | $78.86 | $74.97 | $75.76 | 515.00K |
| Aug 7 | $77.09 | $78.59 | $74.33 | $78.25 | 1.02M |